Future Thinking France launches pharma healthcare division
The new division will be known as Future Thinking Pharma and will be headed by Béatrice Chemla (pictured), previously founder and CEO of Listening Pharma.
The company said its 20% growth in the past 12 months has enabled it to diversify into the pharmaceutical and healthcare sector, with the intention to further expand its blue chip client roster across Europe.
Stéphane Marder, CEO at Future Thinking France, said: “Strengthening and formalising our healthcare expertise will enable us to offer the pharmaceutical industry unique and innovative tools developed by Quantum Lab, our in-house think tank of new ideas, approaches and products.”
We hope you enjoyed this article.
Research Live is published by MRS.
The Market Research Society (MRS) exists to promote and protect the research sector, showcasing how research delivers impact for businesses and government.
Members of MRS enjoy many benefits including tailoured policy guidance, discounts on training and conferences, and access to member-only content.
For example, there's an archive of winning case studies from over a decade of MRS Awards.
Find out more about the benefits of joining MRS here.
0 Comments